Blood Advances

Elsevier

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Blood Advances is an open-access journal published by Elsevier in United States, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,000 USD. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier
ISSN
2473-9529 · 2473-9537
Country
United States
Languages
english
Access
Open access
Declared publication charge
4,000 USD
Articles in DOAJ
1605
Declared review time
16 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2024-07-05
  • MEDLINE · 2017-01-01
  • PUBMED · 2016-11-29
Indexing
DOAJ · MEDLINE · PUBMED
APC
4,000 USD
Declared review time (DOAJ)
16 weeks
Actual review time (measured)
108 days received→accepted — computed from PubMed (n=85)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

1605

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

16weeks

Works in OpenAlex

6108

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

130

i10-index

3450

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2026-04-27
Added to DOAJ
2024-07-05
Declared plagiarism screening
Not declared
Other fees beyond APC
Yes
Declared digital preservation
CLOCKSSPMCPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
92%
ORCID iDs in current deposits
94%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101698425
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Specialties of internal medicine

LCC codes

RC581-951

Subject areas

  • Acute Myeloid Leukemia Research
  • Acute Myeloid Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • CAR-T cell therapy research
  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cell Transplantation
Show all subjects (50)
  • Chronic Lymphocytic Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Platelet Disorders and Treatments
  • Platelet Disorders and Treatments
  • Acute Lymphoblastic Leukemia research
  • Acute Lymphoblastic Leukemia research
  • Hemoglobinopathies and Related Disorders
  • Hemoglobinopathies and Related Disorders
  • Immune Cell Function and Interaction
  • Immune Cell Function and Interaction
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Multiple Myeloma Research and Treatments
  • Multiple Myeloma Research and Treatments
  • Chronic Myeloid Leukemia Treatments
  • Chronic Myeloid Leukemia Treatments
  • Blood groups and transfusion
  • Blood groups and transfusion
  • Venous Thromboembolism Diagnosis and Management
  • Venous Thromboembolism Diagnosis and Management
  • Viral-associated cancers and disorders
  • Viral-associated cancers and disorders
  • Blood Coagulation and Thrombosis Mechanisms
  • Blood Coagulation and Thrombosis Mechanisms
  • Iron Metabolism and Disorders
  • Iron Metabolism and Disorders
  • T-cell and B-cell Immunology
  • T-cell and B-cell Immunology
  • Hemophilia Treatment and Research
  • Hemophilia Treatment and Research
  • Erythrocyte Function and Pathophysiology
  • Immunodeficiency and Autoimmune Disorders
  • Erythrocyte Function and Pathophysiology
  • Protein Degradation and Inhibitors
  • Protein Degradation and Inhibitors
  • Immunodeficiency and Autoimmune Disorders
  • CNS Lymphoma Diagnosis and Treatment
  • CNS Lymphoma Diagnosis and Treatment
  • Virus-based gene therapy research
  • Virus-based gene therapy research
  • Complement system in diseases
  • Complement system in diseases

Keywords (DOAJ)

  • medicine
  • internal medicine
  • hematology
  • diseases of the blood and blood-forming organs
  • hematologic oncology
  • vascular biology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: